|
Exosomal drug formulations
|
1R41CA189517-01
|
$225,000
|
$225,000
|
GUPTA, RAMESH
|
3P BIOTECHNOLOGIES, INC.
|
|
SBIR Phase II, Topic 255: Development of Novel Anticancer Agent to Potentiate Se
|
N44CO140040-000
|
$1,478,552
|
$739,276
|
SERRERO, GINETTE
|
A&G PHARMACEUTICAL, INC
|
|
Core Support for Cancer Center
|
3P30CA013330-41S1
|
$75,000
|
$9,000
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Core Support for Cancer Center
|
3P30CA013330-41S2
|
$148,500
|
$17,820
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Core Support for Cancer Center
|
5P30CA013330-41
|
$3,585,248
|
$430,230
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Taxol: Mechanisms of Action and Resistance
|
5R01CA077263-14
|
$390,474
|
$390,474
|
HORWITZ, SUSAN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Tumor expressed B7x accelerates disease and is a novel target for immunotherapy
|
1F31CA183493-01A1
|
$47,676
|
$23,838
|
OHAEGBULAM, KIM
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Inhaled DNA demethylating therapy for lung cancer and bronchial premalignancy
|
5R01CA154755-04
|
$483,713
|
$241,857
|
PEREZ-SOLER, ROMAN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
The Metastatic Cascade: Macrophages Lead the Way
|
5R01CA172451-02
|
$426,219
|
$140,652
|
POLLARD, JEFFREY
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Methylthioadenosine Phosphorylase and AdoMet Synthetase in Cancer
|
2R01CA135405-06A1
|
$268,912
|
$268,912
|
SCHRAMM, VERN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Risk for Lung Cancer, Asthma, and COPD; Integrating Clinical and Airway Biomarke
|
5K24CA139054-05
|
$167,705
|
$167,705
|
SPIVACK, SIMON
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
In Vivo Multiphoton Based Imaging of Complex Cancer Cell Behavior
|
5R01CA164468-04
|
$734,934
|
$220,480
|
VERKHUSHA, VLADISLAV
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
(PQB4) Age-cancer interplay of genome and epi-genome in human lung
|
5R01CA180126-02
|
$679,887
|
$679,887
|
VIJG, JAN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Nemours Community Clinical Oncology Program
|
3U10CA176879-01S1
|
$89,460
|
$7,157
|
SANDLER, ERIC
|
ALFRED I. DU PONT HOSP FOR CHILDREN
|
|
Adolescent Smoking Cessation in Pediatric Primary Care
|
5R01CA140576-05
|
$405,576
|
$405,576
|
KLEIN, JONATHAN
|
AMERICAN ACADEMY OF PEDIATRICS
|
|
RTOG Biospecimen Repository
|
3U24CA114734-08S1
|
$946,151
|
$94,615
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Nicotine Deprivation and Implicit Motivational Processes of Drinking and Smoking
|
3R03CA175870-01A1S1
|
$40,302
|
$40,302
|
COHN, AMY
|
AMERICAN LEGACY FOUNDATION
|
|
Real-Time Patterns of Smoking and Alcohol Use: A Daily Data Analysis
|
5R03CA175870-02
|
$117,817
|
$117,817
|
COHN, AMY
|
AMERICAN LEGACY FOUNDATION
|
|
Social Dynamics of Substance Use in Online Social Networks for Smoking Cessation
|
1R01CA192345-01
|
$468,382
|
$468,382
|
GRAHAM, AMANDA
|
AMERICAN LEGACY FOUNDATION
|
|
Improving Adherence to Web-based Cessation Programs: A Social Network Approach
|
5R01CA155489-04
|
$500,468
|
$500,468
|
GRAHAM, AMANDA
|
AMERICAN LEGACY FOUNDATION
|
|
Examining Social Influences on Young Adult Smoking and Cessation Trajectories
|
1R03CA187756-01
|
$73,842
|
$73,842
|
VILLANTI, ANDREA
|
AMERICAN LEGACY FOUNDATION
|
|
SMOKEFREE ORDINANCE DATABASE, SEPTEMBER 10, 2014 - SEPTEMBER 9, 2015 -- CATALOG
|
261201400350P
|
$10,500
|
$10,500
|
UNKNOWN, UNKNOWN
|
AMERICAN NONSMOKERS' RIGHTS FOUNDATION
|
|
2014 Annual Meeting of the American Society for Investigative Pathology
|
1R13CA186413-01
|
$2,500
|
$825
|
LUSCINSKAS, FRANCIS
|
AMERICAN SOCIETY/INVESTIGATIVE PATHOLOGY
|
|
Practical high resolution microscopy of un-cut, un-embedded lung biopsies
|
1R43CA189522-01
|
$224,684
|
$224,684
|
LEVENE, MICHAEL
|
APPLIKATE TECHNOLOGIES, LLC
|
|
A FAP-Activated Proteasome Inhibitor for Killing Solid Tumors
|
2R42CA156930-02
|
$534,844
|
$534,844
|
JONES, BARRY
|
ARISAPH PHARMACEUTICALS, INC.
|
|
American Indian mHealth Smoking Dependence study (PQ4)
|
7R01CA170336-03
|
$505,033
|
$505,033
|
PETEREIT, DANIEL
|
AVERA MCKENNAN
|
|
Bay Area Tumor Institute CCOP
|
3U10CA045461-24S1
|
$81,028
|
$8,913
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
Lung Cancer Prediction Models Incorporating Exome Data from Extreme Phenotypes
|
1K07CA181480-01A1
|
$127,739
|
$127,739
|
LIU, YANHONG
|
BAYLOR COLLEGE OF MEDICINE
|
|
Chemotherapeutic Agents with Enhanced Selectivity for the Tumor Microenvironment
|
5R01CA140674-05
|
$274,502
|
$90,586
|
PINNEY, KEVIN
|
BAYLOR UNIVERSITY
|
|
A dual acting drug for enhancing radiotherapeutic benefit
|
1R43CA180316-01A1
|
$209,208
|
$209,208
|
NORRIS, ANDREW
|
BCN BIOSCIENCES, LLC
|
|
Virginia Mason Community Clinical Oncology Program
|
3U10CA035192-29S1
|
$86,403
|
$11,232
|
NICHOLS, CRAIG
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Hyperpolarized NMR for Studies of Cancer Therapies Targeting the Warburg Effect
|
5R01CA169470-02
|
$350,219
|
$350,219
|
GRANT, AARON
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Overcoming resistance to tyrosine kinase inhibitors in lung cancer
|
5R01CA169259-02
|
$350,219
|
$350,219
|
KOBAYASHI, SUSUMU
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Role of POZ-zinc finger proteins in tumorigenesis.
|
5R01CA102142-10
|
$321,009
|
$109,143
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Role of DOK family proteins in lung tumor suppression
|
5R01CA142787-05
|
$339,713
|
$339,713
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Feasibility of grape seed extract for lung cancer chemoprevention
|
5R21CA173211-02
|
$26,283
|
$26,283
|
MAO, JENNY
|
BIOMEDICAL RESEARCH INSTITUTE OF NEW MEX
|
|
The MB-CCOP at Boston Medical Center
|
3U10CA139519-03S5
|
$110,177
|
$12,119
|
KACHNIC, LISA
|
BOSTON MEDICAL CENTER
|
|
Flexible, Conformal, Polymeric Films for Lung Resection Margins
|
5R01CA149561-04
|
$336,653
|
$336,653
|
GRINSTAFF, MARK
|
BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
|
|
Modeling bi-directional signaling and cytoskeletal dynamics in 3D cell migrations
|
5U01CA177799-02
|
$607,019
|
$303,510
|
ZAMAN, MUHAMMAD
|
BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
|
|
A Follow-up Study for Causes of Cancer in Black Women
|
5UM1CA164974-03
|
$1,262,499
|
$252,500
|
ROSENBERG, LYNN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Defining lineage-specific determinants of K-Ras ""addiction"" in human cancers
|
5R00CA149169-05
|
$231,443
|
$76,376
|
SINGH, ANURAG
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Molecular biomarkers of airway and lung linking COPD and Lung Cancer
|
5R01CA164783-04
|
$499,578
|
$499,578
|
SPIRA, AVRUM
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
1U10CA180821-01
|
$10,540,919
|
$1,054,092
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-01S1
|
$228,063
|
$22,806
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-01S2
|
$264,661
|
$26,466
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-01S3
|
$16,838
|
$1,684
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B Human Specimen Repositories
|
3U24CA114725-09S1
|
$1,014,550
|
$507,275
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Women's Health Study: Continued Follow-up
|
5R01CA047988-23
|
$1,780,348
|
$356,070
|
BURING, JULIE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Molecular Pathogenesis of the Hamartoma Syndromes
|
5P01CA120964-08
|
$1,727,206
|
$690,882
|
KWIATKOWSKI, DAVID
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
CT Volume Measurement of Lung Cancer treated with Erlotinib: Genomic Correlation
|
5K23CA157631-04
|
$180,360
|
$180,360
|
NISHINO, MIZUKI
|
BRIGHAM AND WOMEN'S HOSPITAL
|
Total relevant funding to Lung for this search: $254,158,823
|